Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Transact Technologies (TACT) Cash & Equivalents (2016 - 2025)

Transact Technologies' Cash & Equivalents history spans 15 years, with the latest figure at $11.3 million for Q3 2024.

  • For Q3 2024, Cash & Equivalents fell 2.26% year-over-year to $11.3 million; the TTM value through Sep 2024 reached $11.3 million, down 2.26%, while the annual FY2023 figure was $12.3 million, N/A changed from the prior year.
  • Cash & Equivalents for Q3 2024 was $11.3 million at Transact Technologies, up from $11.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $19.5 million in Q4 2021 and bottomed at $615000.0 in Q1 2020.
  • The 5-year median for Cash & Equivalents is $10.5 million (2020), against an average of $9.2 million.
  • The largest annual shift saw Cash & Equivalents tumbled 68.36% in 2020 before it skyrocketed 1870.22% in 2021.
  • A 5-year view of Cash & Equivalents shows it stood at $10.4 million in 2020, then surged by 87.83% to $19.5 million in 2021, then plummeted by 67.29% to $6.4 million in 2022, then soared by 93.6% to $12.3 million in 2023, then decreased by 7.94% to $11.3 million in 2024.
  • Per Business Quant, the three most recent readings for TACT's Cash & Equivalents are $11.3 million (Q3 2024), $11.1 million (Q2 2024), and $10.6 million (Q1 2024).